Fructooligosaccharides (FOS) para Chronic Constipation

Q: Does Fructooligosaccharides (FOS) help with Chronic Constipation?

Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).

Q: How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?

We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Conclusión

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Key Study Findings

Review

Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.

Dose: None vs: None Outcome: gut health outcomes including microbiota modulation and SCFA … Efecto: None None

Población: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis

Randomized Controlled Trial n=67 4 weeks Double-blind

Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …

Dose: None vs: Placebo Outcome: Weekly spontaneous bowel movements Efecto: 4.94 vs 3.00 (P<0.001) P<0.001

Población: Older adults >=60 with functional constipation (Rome IV)

Other

Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …

Dose: 2 g vs: None Outcome: Constipation symptoms Efecto: None P < 0.05

Población: Constipation patients

Randomized Controlled Trial Double-blind

Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.

Dose: 6 g vs: Placebo Outcome: Constipation symptoms Efecto: None None

Población: Constipation patients

Systematic Review

Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Dose: None vs: None Outcome: Constipation symptoms Efecto: OR: 10.36 p < 0.00001

Población: Constipation patients

Randomized Controlled Trial Double-blind

Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.

Dose: None vs: Placebo Outcome: Constipation symptoms Efecto: None None

Población: Constipation patients

Key Statistics

Estudios

350

Participantes

↑

Positive

Calificación

Referenced Papers

Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions. Review

Nutrients 2026 1 citas

Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, … RCT

The journal of … 2025

Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium. Other

Food science & … 2024 17 citas

Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Review

Foods (Basel, Switzerland) 2024 8 citas

Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics. Review

Journal of Parkinson's … 2024 4 citas

Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned piglets. Other

Animal nutrition (Zhongguo … 2024 4 citas

Inulin as a functional ingredient and their applications in meat products. Review

Carbohydrate polymers 2022 77 citas

In vitro Study of Bifidobacterium lactis BL-99 With Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota. Other

Frontiers in nutrition 2022 22 citas

Effects of β-Fructans Fiber on Bowel Function: A Systematic Review and Meta-Analysis. Meta-Analysis

Nutrients 2019 35 citas

Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation. RCT

Nutrients 2018 30 citas

Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and … Review

Journal of the … 2017 447 citas

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double … RCT

Neurogastroenterology and motility 2017 131 citas

Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month. RCT

Nutrients 2017 28 citas

Effectiveness of nutritional treatment and synbiotic use on gastrointestinal symptoms reduction in HIV-infected patients: Randomized clinical trial. RCT

Clinical nutrition (Edinburgh, … 2017 20 citas

Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients. RCT

Peritoneal dialysis international … 2016 38 citas

Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review. Review

World journal of … 2014 16 citas

Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response. RCT

Clinical nutrition (Edinburgh, … 2013

Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents--a placebo-controlled, diet-controlled trial. CCT

Nutrition (Burbank, Los … 2011 65 citas

Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults. RCT

Journal of medicinal … 2011 24 citas

Dietary fructooligosaccharides and potential benefits on health. Review

Journal of physiology … 2009 312 citas

Constipation in long-term care. Review

Journal of the … 2007 84 citas

Novel physiological function of fructooligosaccharides. Review

BioFactors (Oxford, England) 2004 48 citas

Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial. RCT

The British journal … 2003 97 citas

Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis. RCT

Journal of renal … 1998 71 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:: 2-10 g/day
prebioticeffect:: 5-8 g/day for bifidogenic effect
constipationsupport:: 5-10 g/day

Límite superior: Well-tolerated up to 20 g/day; start low to avoid excess gas

Dosificaciones estudiadas en la investigación

Dosificación	Duración	Efecto	N
None	--	Positive	--
None	4 weeks	Positive	67
2 g	--	Neutral	--
6 g	--	Positive	--
None	--	Positive	--
None	--	Positive	--
None	--	Mixed	--
None	--	Positive	--

Mejor momento para tomar: With meals; divide doses throughout the day

Safety & Side Effects

Efectos secundarios reportados

⚠ Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
⚠ Abdominal cramping at higher doses
⚠ May worsen IBS symptoms in FODMAP-sensitive individuals
⚠ Loose stools at excessive doses

Interacciones conocidas

● Other FODMAPs (cumulative fermentation effect in sensitive individuals)
● Blood sugar-lowering medications (FOS may modestly affect glycemic response)
● Calcium supplements (FOS may enhance calcium absorption)

Ingesta máxima tolerable: Well-tolerated up to 20 g/day; start low to avoid excess gas

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Chronic Constipation?

Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).

How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?

We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

Otros ingredientes para Chronic Constipation

Psyllium Husk A Inulin B Bifidobacterium lactis B

Fructooligosaccharides (FOS) para otras condiciones

Irritable Bowel Syndrome (IBS) D

Veredicto rápido

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Evidence Strength52%

Moderate confidence

Desglose de estudios

RCT (10)Meta (1)Other (0)

Comparar alternativas

Vea cómo se comparan otros ingredientes para esta condición.

Ver todos los ingredientes para Chronic Constipation

Más información

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.